Cargando…
Long-acting muscarinic antagonists for the treatment of asthma in children—a new kid in town
BACKGROUND: Asthma is the most prevalent chronic airway disease observed in children and adolescents, yet the variety of treatment options available for this age group is limited. With many factors influencing therapeutic efficacy including patient knowledge, adherence, and therapy choice as well as...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Medizin
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208794/ https://www.ncbi.nlm.nih.gov/pubmed/30416934 http://dx.doi.org/10.1007/s40629-018-0066-y |